The News
Roche has announced it possesses nearly 3,500 GPUs, claiming the largest GPU footprint in the pharmaceutical industry, significantly surpassing Recursion Pharmaceuticals' 504-GPU supercomputer unveiled in May 2024.
Why It Matters
This development underscores Roche's commitment to leveraging advanced AI infrastructure for drug discovery and development, potentially accelerating innovation in pharmaceuticals. The lack of publicly tied clinical candidates suggests a strategic focus on building computational capabilities ahead of tangible outputs.
Key Evidence
The information is derived from a reliable source, rdmag, reporting on Roche's announcement at NVIDIA's GTC event.
Original Article
rdmag
EN source 路 Published yesterday
https://www.rdworldonline.com/roche-claims-pharmas-largest-gpu-footprint-at-nvidias-flagship-gtc-event/